Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data support use of SFP in hemodialysis-dependent patients with CKD

July 7, 2010

Safety and antitumor activity of BMS-754807 reported in phase I trial

July 7, 2010

SBR-759 superior to sevelamer HCI for hyperphosphatemia in Asian hemodialysis patients

July 6, 2010

Brivaracetam dose adjustment not needed for renal dysfunction

July 6, 2010

Genetic variations linked to pancreatic cancer risk

July 6, 2010

Maximum tolerated dose of acadesine identified in chronic lymphocytic leukemia patients

July 6, 2010

Multikinase inhibitor regorafenib evaluated in NSCLC; interim phase I data presented

July 6, 2010

Genetic profiles of patients responding to antihypertensive rostafuroxine identified

July 5, 2010

GPR119 agonist AS-1535907 regulates insulin expression and pancreatic beta-cell mass in vivo

July 5, 2010

Preliminary phase I data on HDAC inhibitor CHR-3996 in advanced solid tumors disclosed

July 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...